Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome

類似資料

• Cebranopadol: A First-in-Class Nociceptin Receptor Agonist for Managing Chronic Pain
  著者:: Nair, Abhijit S, 等
  出版事項: (2020)
• Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome
  著者:: Cardinale, Michael, 等
  出版事項: (2020)
• Anesthetic-induced developmental neurotoxicity: causes, prospective studies and possible interventions
  著者:: Nair, Abhijit S., 等
  出版事項: (2017)
• Acute gastric conduit dilatation after oesophagectomy as a cause of respiratory distress
  著者:: Nair, Abhijit S, 等
  出版事項: (2018)
• Innovative Method to Deal with Pericatheter Leak in Home-based Management of Malignant Ascites
  著者:: Suvvari, Praneeth, 等
  出版事項: (2020)